Overview

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of chemoradiotherapy combined with tirelizumab in the treatment of initial unresectable locally advanced gastric cancer or gastroesophageal junction cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Zhejiang Cancer Hospital